🇺🇸 FDA
Pipeline program

A study to test how well multiple doses of BI 765423 are tolerated by healthy men

1493-0008

Phase 1 other active

Quick answer

A study to test how well multiple doses of BI 765423 are tolerated by healthy men for Healthy volunteer trial is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim International GmbH
Indication
Healthy volunteer trial
Phase
Phase 1
Modality
other
Status
active

Clinical trials